Global Gene Expression Analysis Market Size study, by Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Microarrays, Others), by Product Type (Instruments, Reagents and Consumables, Services), by End-user (Drug Discovery & Dev

Global Gene Expression Analysis Market Size study, by Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Microarrays, Others), by Product Type (Instruments, Reagents and Consumables, Services), by End-user (Drug Discovery & Development, Diagnostic Laboratories, Academic Research Centers) and Regional Forecasts 2022-2032

Global Gene Expression Analysis Market is valued at approximately USD 3.89 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.10% over the forecast period 2024-2032. Gene expression analysis is the study of the activity of genes in a cell or tissue at a given moment. It involves measuring the levels of messenger RNA (mRNA) produced from each gene, as mRNA is the intermediate molecule between DNA and protein synthesis. This process provides insights into which genes are being actively transcribed and can give clues about the functional state of cells or tissues under different conditions. Moreover, the key trend of Gene Expression Analysis Market is growing interest in integrating gene expression data with other omics data types, such as genomics, epigenomics, proteomics, and metabolomics, to gain a more comprehensive understanding of biological systems. Integrated multi-omics approaches allow researchers to uncover complex interactions and regulatory networks underlying cellular processes and disease mechanisms.

The shift towards personalized medicine approaches, which aim to tailor medical treatments to individual patients based on their molecular profiles, has increased the demand for the Gene Expression Analysis market. Gene expression profiling enables the identification of biomarkers, prediction of treatment responses, and stratification of patient populations for more targeted and effective therapies. Additionally, other factors support the market growth are increasing focus on biomarker discovery, expanding applications in drug development, and increasing investments in life sciences research, particularly in fields such as oncology, immunology, neurology, and infectious diseases, are fueling the demand for gene expression analysis tools and services. However, the lack of skilled labor, and the high cost of the Instruments are expected to hinder the market growth during the forecast period 2024-2032.

The key regions considered for the global Gene Expression Analysis market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America holds a leading position in the Global Gene Expression Analysis Market and is projected to uphold this dominance in the forecasted period. This trend is propelled by heightened investment and growing research and development activities focused on advancing gene therapy, particularly within the United States. Additionally, the surge in gene expression studies, coupled with governmental initiatives and ample funding allocated for Next-Generation Sequencing (NGS) research, collectively stimulate the expansion of the gene expression analysis market across North America. Also, increasing investment from research institutes, companies, and universities in next-generation sequencing is bolstering regional market growth. For instance, in August 2022, the Department of Health and Human Services unveiled a Funding Opportunity Announcement (FOA) targeting innovative research on structural birth defects. The FOA encompasses diverse areas such as identifying modifier genes affecting defect variability, studying altered gene expression, and exploring epigenetic factors' role in structural birth defects. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period.

Major market player included in this report are:
Thermo Fisher Scientific Inc (US)
Bio-Rad Laboratories Inc. (US)
Illumina Inc (US)
F. Hoffmann-La Roche (Switzerland)
Agilent Technologies Inc (US)
Oxford Gene Technology IP Limited (UK)
Eurofins Scientific (Luxembourg)
Standard BioTools (US)
Oxford Nanopore Technologies plc (UK)
Takara Bio Inc (Japan)

The detailed segments and sub-segment of the market are explained below:

By Technology
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Microarrays
Others

By Product Type
Instruments
Reagents and Consumables
Services

By End-user
Drug Discovery & Development
Diagnostic Laboratories
Academic Research Centers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.